Komori
Earnings7634HOSHIIRYO-SANKI CO.,LTD.Trading & Wholesale

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (Japanese GAAP)

In the first quarter of the fiscal year ending March 2027, revenue increased 1.0% year on year and operating profit increased 7.6%, resulting in higher revenue and profit. The full-year earnings forecast and annual dividend forecast remain unchanged.

Worth reading
32Immaterial
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
7.6
Year-on-year change in operating income (%)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAP
Net Sales3,772¥ millionYear on year +1.0%Progress 24.1%
Operating profit409¥ millionYear on year +7.6%Progress 20.7%
Ordinary income428¥ millionYear on year +8.2%Progress 20.8%
Net income attributable to owners of the parent288¥ millionYear on year +6.9%Progress 20.6%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥92.37
Financial position at period-end
Total assets26,529¥ million
of which net assets 20,441 ¥ millionEquity ratio 75.9%vs. prior year-end +1.1pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueMedical Gas Business ¥977,410 thousand (YoY +0.6%), Home Healthcare Business ¥1,896,177 thousand (YoY +7.3%), Medical Gas Equipment Construction Business ¥223,707 thousand (YoY -24.2%), Nursing Care and Welfare Business ¥305,319 thousand (YoY +5.7%), Residential Care Business ¥85,479 thousand (YoY -2.2%)
Segment profitMedical Gas Business ¥120,883 thousand (YoY -3.3%), Home Healthcare Business ¥195,841 thousand (YoY +9.4%), Medical Gas Equipment Construction Business ¥44,087 thousand (YoY +5.3%), Nursing Care and Welfare Business ¥12,497 thousand, Residential Care Business ¥-1,469 thousand
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥15,660 million (YoY +0.9%)
Operating profit¥1,980 million (YoY +3.2%)
Ordinary income¥2,060 million (YoY +3.0%)
Net income¥1,400 million (YoY +2.0%)
Annual Dividend Forecast¥90 → ¥90(0.0%)
Factors Behind Changes in Business Performance

In the medical gas business, shipments of medical oxygen and carbon dioxide remained firm, but the business was affected by higher material and procurement prices resulting from rising energy costs and transportation expenses. In the home healthcare business, HOT and CPAP remained firm, and efficiency measures were promoted. In the medical gas equipment construction business, soaring construction costs led to declines in capital investment and the cancellation or postponement of construction plans. In the nursing care and welfare business, rental and sales remained firm, while in the residential care business, efforts were made to improve occupancy and operating rates.

Disclosure regarding the going concern assumption

No applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationAdded: 0 companies; excluded: 0 companies
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)No applicable matters.
Depreciation and amortization¥258,208 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End3,420,000 Shares
Treasury Shares at Period-End295,100 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026 to 30 June 2026
Net Sales¥3,772 million (YoY +1.0%)
Operating profit¥409 million (YoY +7.6%)
Ordinary income¥428 million (YoY +8.2%)
Profit attributable to owners of the parent¥288 million (YoY +6.9%)
Net income per share¥92.37
Equity ratioEnd of the current fiscal period 75.9 / End of previous period 74.8
Total assets¥26,529 million
Net assets¥20,441 million
Full-year earnings forecastNet Sales ¥15,660 million (YoY +0.9%) / Operating profit ¥1,980 million (YoY +3.2%) / Ordinary income ¥2,060 million (YoY +3.0%) / Net income ¥1,400 million (YoY +2.0%)
Annual Dividend Forecast¥90 → ¥90(0.0%)
Segment revenueMedical Gas Business ¥977,410 thousand (YoY +0.6%), Home Healthcare Business ¥1,896,177 thousand (YoY +7.3%), Medical Gas Equipment Construction Business ¥223,707 thousand (YoY -24.2%), Nursing Care and Welfare Business ¥305,319 thousand (YoY +5.7%), Residential Care Business ¥85,479 thousand (YoY -2.2%)
Segment profitMedical Gas Business ¥120,883 thousand (YoY -3.3%), Home Healthcare Business ¥195,841 thousand (YoY +9.4%), Medical Gas Equipment Construction Business ¥44,087 thousand (YoY +5.3%), Nursing Care and Welfare Business ¥12,497 thousand, Residential Care Business ¥-1,469 thousand
Depreciation and amortization¥258,208 thousand
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)No applicable matters.
Disclosure regarding the going concern assumptionNo applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationAdded: 0 companies; excluded: 0 companies
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End3,420,000 Shares
Treasury Shares at Period-End295,100 Shares
Factors Behind Changes in Business PerformanceIn the medical gas business, shipments of medical oxygen and carbon dioxide remained firm, but the business was affected by higher material and procurement prices resulting from rising energy costs and transportation expenses. In the home healthcare business, HOT and CPAP remained firm, and efficiency measures were promoted. In the medical gas equipment construction business, soaring construction costs led to declines in capital investment and the cancellation or postponement of construction plans. In the nursing care and welfare business, rental and sales remained firm, while in the residential care business, efforts were made to improve occupancy and operating rates.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Shipments of medical oxygen and carbon dioxide remained firm, while in home healthcare, HOT and CPAP remained firm and the company promoted efficiency measures through its own efforts. In the nursing care and welfare business, rental and sales remained firm, while the medical gas equipment construction business secured stable revenue from maintenance inspections and repairs. Meanwhile, the business was affected by higher energy costs, transportation expenses and raw material prices, as well as declines in capital investment and the cancellation or postponement of construction plans due to soaring construction costs.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (Japanese GAAP) | HOSHIIRYO-SANKI CO.,LTD. (7634) timely disclosure | Komori